Omega-3 Fatty Acids (EPA/DHA) के लिए Crohn's Disease
CEPIC-1 and EPIC-2 large RCTs showed no benefit for maintaining Crohn's remission. Earlier smaller studies were more positive. Current consensus is neutral.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Domega\u002D3\u002Dfatty\u002Dacids\u0026condition\u003Dibd\u002Dcrohns\u002Ddisease';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
निष्कर्ष
EPIC-1 and EPIC-2 large RCTs showed no benefit for maintaining Crohn's remission. Earlier smaller studies were more positive. Current consensus is neutral.
Key Study Findings
Other
Intestinal anti-inflammatory, histopathologic and anti-oxidative regulatory effects of total alkaloids extract from Linum usitatissimum L. …
Dose: 50, 100, and 200 mg/kg oral
बनाम: Dexamethasone 2.4 mg/kg; DNBS colitis model vs healthy
Outcome: Colonic inflammation markers (MPO, NO, MDA, CAT, GSH)
प्रभाव: None
None
जनसंख्या: DNBS-induced Crohn's disease BALB/c mouse model
Review
Gut microbiome-centric nutritional strategies in inflammatory bowel disease: Modulating dysbiosis for therapeutic benefit.
Dose: None
बनाम: None
Outcome: IBD microbiota modulation and immune regulation
प्रभाव: None
None
जनसंख्या: IBD patients (review of nutritional interventions)
Review
Are there Effective Vegan-Friendly Supplements for Optimizing Health and Sports Performance? a Narrative Review.
Dose: None
बनाम: None
Outcome: Athletic performance and nutritional optimization
प्रभाव: None
None
जनसंख्या: Vegan athletes (narrative review)
Other
Interaction between diet and genetics in patients with inflammatory bowel disease.
Dose: None
बनाम: None
Outcome: Diet-genetics interaction in IBD
प्रभाव: None
None
जनसंख्या: IBD patients (editorial commentary)
Review
Association between Omega-3 fatty acids and autoimmune disease: Evidence from the umbrella review and Mendelian …
Dose: None
बनाम: None
Outcome: Colitis severity
प्रभाव: None
None
जनसंख्या: Crohn's disease patients
Observational Study
Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: …
Dose: 95%
बनाम: None
Outcome: inflammation markers
प्रभाव: None
None
जनसंख्या: None
Key Statistics
6
अध्ययन
800
प्रतिभागी
↔
Mixed
C
ग्रेड
Referenced Papers
Semergen
2025
4 उद्धरण
Current nutrition reports
2025
3 उद्धरण
Journal of ethnopharmacology
2025
1 उद्धरण
Autoimmunity reviews
2024
12 उद्धरण
World journal of …
2024
Metabolites
2023
13 उद्धरण
Scientific reports
2020
56 उद्धरण
Gastroenterology clinics of …
2018
67 उद्धरण
International journal of …
2017
143 उद्धरण
Medical principles and …
2017
45 उद्धरण
Ugeskrift for laeger
2017
European journal of …
2016
79 उद्धरण
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Review
Current pharmaceutical design
2016
32 उद्धरण
Clinics in dermatology
2016
19 उद्धरण
The Cochrane database …
2014
88 उद्धरण
Alimentary pharmacology & …
2013
128 उद्धरण
The British journal …
2012
145 उद्धरण
Dietary supplements for established atopic eczema.
Meta-Analysis
The Cochrane database …
2012
130 उद्धरण
World journal of …
2012
113 उद्धरण
Frontline gastroenterology
2012
20 उद्धरण
Pediatrics in review
2012
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.
Systematic Review
The American journal …
2011
946 उद्धरण
Inflammatory bowel diseases
2011
195 उद्धरण
Nutrition in clinical …
2011
1 उद्धरण
The Cochrane database …
2009
198 उद्धरण
Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
Review
Alimentary pharmacology & …
2008
50 उद्धरण
The American journal …
2007
310 उद्धरण
Digestion
2007
15 उद्धरण
The Cochrane database …
2007
2 उद्धरण
Gastroenterology nursing : …
2006
24 उद्धरण
World journal of …
2005
80 उद्धरण
Alimentary pharmacology & …
2005
50 उद्धरण
Immunonutrition.
Review
Current opinion in …
2005
22 उद्धरण
Nutricion hospitalaria
2003
Journal of the …
2002
2016 उद्धरण
Enteral feeding.
Other
Current opinion in …
2002
1 उद्धरण
Enteral feeding.
Review
Current opinion in …
2002
Zeitschrift fur Gastroenterologie
1998
18 उद्धरण
Scandinavian journal of …
1996
195 उद्धरण
Arquivos de gastroenterologia
1996
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
सामान्य रूप से उपयोग की जाने वाली खुराकें
- general:
- 1,000-2,000 mg combined EPA/DHA per day
- ibdsupport:
- 2,000-4,000 mg/day combined EPA/DHA (higher EPA ratio may be more beneficial)
अधिकतम सीमा: 3,000 mg/day combined EPA/DHA (FDA GRAS limit)
अनुसंधान में अध्ययन की गई खुराकें
| खुराक | अवधि | प्रभाव | N |
|---|---|---|---|
| 50, 100, and 200 mg/kg oral | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Neutral | -- |
| None | -- | Neutral | -- |
| 95% | -- | Mixed | -- |
| None | -- | Mixed | 12194 |
| None | -- | Mixed | -- |
सेवन का सर्वोत्तम समय: With meals containing fat for better absorption
Safety & Side Effects
रिपोर्ट किए गए दुष्प्रभाव
- ⚠ Fishy aftertaste and burping
- ⚠ Mild gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Potential increased bleeding time at very high doses (>3 g/day)
- ⚠ May lower blood pressure slightly
ज्ञात अंतःक्रियाएँ
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
- ● Cyclosporine (fish oil may reduce cyclosporine nephrotoxicity but monitor levels)
सहनीय अधिकतम सेवन: 3,000 mg/day combined EPA/DHA (FDA GRAS limit)
कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
Frequently Asked Questions
Does Omega-3 Fatty Acids (EPA/DHA) help with Crohn's Disease?
Based on 6 studies with 800 participants, there is limited but promising evidence that Omega-3 Fatty Acids (EPA/DHA) may support Crohn's Disease management. Our evidence grade is C (Some Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Crohn's Disease?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined EPA/DHA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Mild gastrointestinal discomfort (nausea, diarrhea), Potential increased bleeding time at very high doses (>3 g/day), May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Crohn's Disease?
We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 800 total participants. The overall direction of effect is mixed.
Related Evidence
इसके लिए अन्य सामग्री Crohn's Disease
Omega-3 Fatty Acids (EPA/DHA) अन्य स्वास्थ्य स्थितियों के लिए
FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।